Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotectionJan Kubeš, Matthew J. Schellenberg, Lise C. M. Arrouye et al.|Nature Communications|2025Cited by 14
Dimerization-dependent serine protease activity of FAM111A prevents replication fork stalling at topoisomerase 1 cleavage complexesSowmiya Palani, Yuichi Machida, Yuka Machida et al.|Nature Communications|2024Cited by 13
Topobexin Targets a Unique Druggable Pocket of Topoisomerase II for Beta Isoform- Selective Control of DNA Damage During Anthracycline ChemotherapyJan Kubeš, Matthew J. Schellenberg, Galina Karabanovich et al.|Structural Dynamics|2025Cited by 0
Molecular basis of allosteric regulation and pharmaceutical targeting of protein kinase CβAnh Cong, Matthew J. Schellenberg, Taylor L. Witter et al.|Nature Communications|2026Cited by 0
SV40 Large T antigen inhibits the host serine protease FAM111A through a zinc-dependent, cleavage-avoiding mechanismAllison L Welter, Sudhaker Dharavath, Yuka Machida et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0